ClinicalTrials.Veeva

Menu

Prospective Cohort of Patients With Intracerebral Hemorrhage

D

De-zhi Kang

Status

Enrolling

Conditions

Intracerebral Hemorrhage
Stroke, Acute

Study type

Observational

Funder types

Other

Identifiers

NCT06670456
2022ZD01003

Details and patient eligibility

About

The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI);
  • Underwent no surgical intervention;

Exclusion criteria

  • Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma)
  • Pre-stroke life expectancy < 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure [NYHA: III-IV], severe chronic obstructive pulmonary disease [III-IV], chronic kidney disease requiring hemodialysis)
  • Severe dependency or incorporation to interview (e.g., pre-stroke mRS>3, severe dementia, intractable mental disease)
  • Unsuitable for inclusion in the study in the opinion of the investigator

Trial contacts and locations

6

Loading...

Central trial contact

De-zhi Kang, MD; Fu-xin Fu-xin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems